Chronic Pain News and Research

RSS

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation.

31 Aug 2010

Canada hosts 13th World Congress On Pain

The Canadian Pain Society (CPS) eagerly welcomes leading pain experts from across Canada and around the globe to the 13th World Congress on Pain in Montreal, Quebec, from August 29 to September 2. Hosted by the International Association for the Study of Pain (IASP), more than 6,000 pain professionals will gather to share their thoughts, research and best treatment practices concerning this throbbing public health issue.

30 Aug 2010

ACTION Ontario encourages provincial narcotics strategy announcement

ACTION Ontario, a non-profit group advocating on behalf of chronic pain sufferers, welcomes the announcement of a provincial narcotics strategy and encourages the government to act on the underlying issue of chronic pain.

30 Aug 2010

Researchers find smoked cannabis reduces chronic neuropathic pain

For people suffering chronic pain, smoked cannabis reduces pain, improves mood and helps sleep, according to new research published in CMAJ.

30 Aug 2010

Study finds common risk factors linked with painkiller addiction

A new Geisinger study begins to unlock the puzzle of painkiller (opioid) addiction - why some people are more likely to become addicted than others. Geisinger investigators have found that patients with four common risk factors have a significantly higher risk of addiction. In addition, a history of severe drug dependence and drug abuse compounds the risk.

30 Aug 2010

RAND Corporation study reveals shortage of anesthesiologists, nurse anesthetists

A recent study from the RAND Corporation, one of the country's most trusted analytic organizations, finds a current shortage of 3,800 anesthesiologists and 1,282 nurse anesthetists. However, if current trends continue, a dramatic shortage of anesthesiologists and a significant surplus of nurse anesthetists are projected by 2020.

26 Aug 2010

Assured Pharmacy reports 20.8% increase in same store sales

OTC Stock Review announces that it has initiated coverage of Assured Pharmacy, Inc. Assured Pharmacy, a growing chain of specialty pharmacies specializing in servicing patients who live with chronic pain, just reported a 20.8 percent increase in same store sales for June 2010 versus June 2009.

24 Aug 2010

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

The U.S. Food and Drug Administration (FDA) Anesthetic and Life Support Drugs Advisory Committee voted 8-6 in favor of expanding the pain indications for Eli Lilly and Company's (NYSE: LLY) Cymbalta® (duloxetine HCl) to a broader pain population that will be further defined by the FDA, if approved.

20 Aug 2010

USPTO grants Collegium second patent for tamper-resistant DETERx formulation platform

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper-resistant DETERx™ formulation platform. US Patent Number 7,771,707 contains claims that cover Collegium's proprietary extended-release formulations, which are designed to resist dose dumping when subjected to a variety of physical methods of tampering.

18 Aug 2010

$Study finds link between osteoporosis, fracture$

Study finds link between osteoporosis, fracture

An international study of more than 60,000 women has drawn new light on the relationship between osteoporosis and fractures.Scientists call for more to be done to identify and treat patients at the highest risk of fractures.Osteoporosis is more common in women who have fractured bones when they were younger and they experience a similar loss in health-related quality of life as those with arthritis, lung disease, diabetes and other chronic diseases.

18 Aug 2010

Study finds black patients receive fewer opoid medications than whites

Black patients are prescribed fewer pain medications than whites and few women receive medications strong enough to manage their chronic pain, according to a study in the August issue of Journal of Pain.University of Michigan Health System researchers studied nearly 200 patients with chronic pain who sought help from a specialty pain center. Researchers analyzed the number and potency of medicines they were already taking and the adequacy of pain management.

18 Aug 2010

Discovery can lead to new class of drugs for chronic pain treatment

Researchers have made a discovery that could lead to a brand new class of drugs to treat chronic pain caused by inflammatory conditions such as arthritis and back pain without numbing the whole body.

17 Aug 2010

Deconstruction of biomedical research on pain will improve diagnosis, treatment of chronic pain sufferers

Is the science of diagnosing pain causing a number of pain sufferers to defend their honor? Research out of the University of Cincinnati is examining the diagnosis of pain that evades scientific testing, and the additional emotional suffering that can result for the patient.

17 Aug 2010

Chronic pain affects higher proportion of women than men: Research

Women experience chronic pain longer, more intensely and more often than men, according to a psychologist who works with both men and women dealing with diseases and conditions that leave them suffering.

13 Aug 2010

Trigemina reports positive results from TI-001 Phase IIa clinical trial for Chronic Daily Headache

Trigemina, Inc., a Mountain View, CA based pharmaceutical company, reports positive results from its Phase IIa proof-of-concept clinical trial for TI-001 in Chronic Daily Headache. The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston, and compares intranasal TI-001 with placebo in patients suffering from CDH.

11 Aug 2010

Endo to acquire Penwest for $5.00 per share

Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.

10 Aug 2010

Millennium Laboratories signs agreement to assist physicians with drug monitoring services, tools

Millennium Laboratories, Inc., a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today a national agreement with MultiPlan, the nation's leading comprehensive provider of healthcare cost management solutions. As a participating provider in the PHCS and MultiPlan Networks, Millennium Laboratories will assist participating physicians with state-of-the-art therapeutic drug monitoring services and tools.

9 Aug 2010

Adversity-exposure may protect against psychiatric disturbances that occur with CBP: Study

A new study by researchers at the University at Buffalo and the University of California, Irvine, to be published in the September issue of the journal Pain, reveals that, for people with chronic back pain, having a little adversity in your life can be protective and beneficial.

6 Aug 2010

Researchers identify gene associated with susceptibility to chronic pain caused by nerve injury

Researchers at the Hebrew University of Jerusalem and elsewhere have succeeded in identifying for the first time a gene associated with susceptibility to chronic pain caused by nerve injury in humans, signaling a significant step toward better understanding and treating of the condition.

6 Aug 2010

Gene associated with susceptibility to chronic pain caused by nerve injury identified

Researchers at the Hebrew University of Jerusalem and elsewhere have succeeded in identifying for the first time a gene associated with susceptibility to chronic pain caused by nerve injury in humans, signalling a significant step toward better understanding and treating of the condition.

5 Aug 2010

Chronic Pain News and Research

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Canada hosts 13th World Congress On Pain

ACTION Ontario encourages provincial narcotics strategy announcement

Researchers find smoked cannabis reduces chronic neuropathic pain

Study finds common risk factors linked with painkiller addiction

RAND Corporation study reveals shortage of anesthesiologists, nurse anesthetists

Assured Pharmacy reports 20.8% increase in same store sales

FDA Advisory Committee votes in favor of expanding pain indications for Eli Lilly's Cymbalta

USPTO grants Collegium second patent for tamper-resistant DETERx formulation platform

Study finds link between osteoporosis, fracture

Study finds black patients receive fewer opoid medications than whites

Discovery can lead to new class of drugs for chronic pain treatment

Deconstruction of biomedical research on pain will improve diagnosis, treatment of chronic pain sufferers

Chronic pain affects higher proportion of women than men: Research

Trigemina reports positive results from TI-001 Phase IIa clinical trial for Chronic Daily Headache

Endo to acquire Penwest for $5.00 per share

Millennium Laboratories signs agreement to assist physicians with drug monitoring services, tools

Adversity-exposure may protect against psychiatric disturbances that occur with CBP: Study

Researchers identify gene associated with susceptibility to chronic pain caused by nerve injury

Gene associated with susceptibility to chronic pain caused by nerve injury identified

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News